Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation

Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation

10.1097/01.tp.0000166921.14670.33

Saved in:
Bibliographic Details
Main Authors: Vathsala, A, Ona, ET, Tan, SY, Suresh, S, Lou, HX, Casasola, CBC, Wong, HC, Machin, D, Chiang, GSC, Danguilan, RA, Calne, R
Other Authors: SURGERY
Format: Article
Published: Ovid Technologies (Wolters Kluwer Health) 2022
Subjects:
Adolescent
Adult
Aged
Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Cyclosporine
Female
Graft Rejection
Humans
Immunotherapy
Kidney
Kidney Function Tests
Kidney Transplantation
Male
Middle Aged
Time Factors
Online Access:https://scholarbank.nus.edu.sg/handle/10635/229456
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

https://scholarbank.nus.edu.sg/handle/10635/229456

Similar Items